The Archer FusionPlex ALL Kit is a targeted next-generation sequencing assay that detects and identifies fusions, point mutations and expression levels from RNA input. The kit is comprehensive in nature, targeting 81 genes associated with Acute
Lymphoblastic Leukemia, including all recurrent Ph-Like ALL fusion events. Using Archer’s proprietary Anchored Multiplex PCR-based enrichment (AMPTM), fusions of all genes in this kit can be identified in a single sequencing assay,
even without prior knowledge of fusion partners or breakpoints. Additionally, select genes are targeted for molecular barcode-enabled relative expression level detection and point mutation coverage.